Please use this identifier to cite or link to this item:
Title: The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.
Authors: Serrano-Villar, S
Vázquez-Castellanos, J F
Vallejo, A
Latorre, A
Sainz, T
Ferrando-Martínez, S
Rojo, D
Martínez-Botas, J
Del Romero, J
Madrid, N
Leal, M
Mosele, J I
Motilva, M J
Barbas, C
Ferrer, M
Moya, A
Moreno, S
Gosalbes, M J
Estrada, V
metadata.dc.subject.mesh: Adult
Dietary Supplements
Gastrointestinal Microbiome
HIV Infections
Host-Pathogen Interactions
Intestinal Mucosa
Middle Aged
Placebo Effect
RNA, Ribosomal, 16S
Issue Date: 21-Dec-2016
Abstract: Altered interactions between the gut mucosa and bacteria during HIV infection seem to contribute to chronic immune dysfunction. A deeper understanding of how nutritional interventions could ameliorate gut dysbiosis is needed. Forty-four subjects, including 12 HIV+ viremic untreated (VU) patients, 23 antiretroviral therapy-treated (ART+) virally suppressed patients (15 immunological responders and 8 non-responders) and 9 HIV- controls (HIV-), were blindly randomized to receive either prebiotics (scGOS/lcFOS/glutamine) or placebo (34/10) over 6 weeks in this pilot study. We assessed fecal microbiota composition using deep 16S rRNA gene sequencing and several immunological and genetic markers involved in HIV immunopathogenesis. The short dietary supplementation attenuated HIV-associated dysbiosis, which was most apparent in VU individuals but less so in ART+ subjects, whose gut microbiota was found more resilient. This compositional shift was not observed in the placebo arm. Significantly, declines in indirect markers of bacterial translocation and T-cell activation, improvement of thymic output, and changes in butyrate production were observed. Increases in the abundance of Faecalibacterium and Lachnospira strongly correlated with moderate but significant increases of butyrate production and amelioration of the inflammatory biomarkers soluble CD14 and high-sensitivity C-reactive protein, especially among VU. Hence, the bacterial butyrate synthesis pathway holds promise as a viable target for interventions.
metadata.dc.identifier.doi: 10.1038/mi.2016.122
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.